HOME >> BIOLOGY >> NEWS
NIH renews funding for continued Rb2 tumor suppressing gene research at Temple

Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute for Cancer Research and Molecular Medicine, and co-director of the Center for Biotechnology in Temple University's College of Science and Technology, has been awarded a five-year, $1.68 million grant from the National Institutes of Health (NIH) to continue his exploration of the role the tumor suppressing gene Rb2/p130 plays in cancer. An internationally recognized researcher in the genetics of cancer and gene therapy, Giordano discovered Rb2/p130 in the early 1990s while serving as a member of Temple's School of Medicine faculty and as a researcher at the Fels Institute for Cancer Research and Molecular Biology.

Over the past decade, Giordano and the other researchers at the Sbarro Institute (http://www.shro.org) have been able to establish a link between Rb2 and its expression with the regression of cancer in the lungs, the aggression of cancer in the liver and ovaries, the effectiveness of drug therapies against breast cancer, and as a potential prognosticator of prostate cancer.

"The grant from NIH is recognition of our hard and creative work on Rb2/p130 over the past 12 years," says Giordano. "With this funding, we will be able to attain a more in-depth understanding of the molecular mechanisms behind Rb2 and how it functions, as well as design therapies that will allow us to one day deliver Rb2/p130 quickly and safely into cancer patients."

In addition to Rb2/p130, Giordano also discovered two other genes in 1992, CDK9 (cyclin-dependent kinase) and CDK10 (PISSLRE), major guardians of the human genome. CDK9 has proved to be multi-functional, with the discovery of its important roles in cell differentiation, HIV transcription and tumorigenesis.

The author of more than 200 published articles, Giordano has done pioneering work in the fields of cell cycle, gene therapy and the genetics of cancer, paving the way to the development of new di
'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
27-Jul-2004


Page: 1 2 3

Related biology news :

1. Grant renews funding of research toward cloning primates
2. HHMI renews postgraduate education support
3. Maine-based biophysics institute gets funding for first US-based 4Pi nanoscale microscope
4. MSU group reviews Berkeley venture into brave new science funding world
5. University of Pittsburgh receives NIH funding to develop heart assist device for infants
6. UC San Diego faculty receive funding from von Liebig Center to commercialize academic research
7. PDF invites scientists pursuing Parkinsons research to apply for funding
8. Congress allocates funding for horseshoe crab research center
9. Taking aim at bioterrorism: UH professor gets HHS funding to battle anthrax
10. New funding mechanism for melanoma research announced
11. UCF garners nearly $89 million in research funding

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
(Date:4/13/2017)... SANTA MONICA, Calif. , April 13, 2017 /PRNewswire/ ... New York will feature emerging and ... Innovation Summits. Both Innovation Summits will run alongside the ... variety of speaker sessions, panels and demonstrations focused on ... east coast,s largest advanced design and manufacturing event will ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... Market with the addition of its newest module, US Hemostats & Sealants. , ... thrombin hemostats, absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in ...
(Date:10/12/2017)... San Diego, CA (PRWEB) , ... ... ... BioInformatics (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform ... eliminating all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... in its endogenous context, enabling overexpression experiments and avoiding the use of exogenous ... RNA guides is transformative for performing systematic gain-of-function studies. , This complement ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for its ... 2018 in San Francisco, CA. The Summit brings together current and former FDA office ... directors and government officials from around the world to address key issues in device ...
Breaking Biology Technology:
Cached News: